Hutchin Hill Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-417,100
Closed -$6.06M 889
2016
Q4
$6.06M Buy
417,100
+110,900
+36% +$2.03M 0.21% 109
2016
Q3
$7.52M Buy
306,200
+127,448
+71% +$3.3M 0.15% 94
2016
Q2
$3.6M Buy
178,752
+77,900
+77% +$2.21M 0.12% 118
2016
Q1
$2.65M Buy
+100,852
New +$7.46M 0.08% 276
2015
Q2
Sell
-8,700
Closed -$1.73M 657
2015
Q1
$1.73M Buy
+8,700
New +$1.54M 0.05% 332
2014
Q1
Sell
-120,200
Closed -$14.1M 607
2013
Q4
$14.1M Sell
120,200
-45,000
-27% -$4.93M 0.97% 25
2013
Q3
$17.2M Sell
165,200
-219,800
-57% -$21.4M 1.56% 14
2013
Q2
$33.1M Buy
+385,000
New +$30.3M 3.41% 3

Other funds holding BHC

Hutchin Hill Capital's BHC Position: Q1 2017 in Review

Hutchin Hill Capital sold out of Bausch Health (BHC) in Q1 2017, closing a stake of 417,100 shares — an estimated $6.06M sold.

Hutchin Hill Capital first reported a position in BHC in Q2 2013 and held it in 8 quarters. The position peaked at $33.1M in Q2 2013. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2017.

  • Hutchin Hill Capital reported no remaining Bausch Health position as of Q1 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 417,100 Bausch Health shares in Q1 2017, an estimated $6.06M.
  • Hutchin Hill Capital first reported a position in Bausch Health in Q2 2013 and held it in 8 quarters.
  • Hutchin Hill Capital's Bausch Health position peaked at $33.1M in Q2 2013.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2017.

Based on Hutchin Hill Capital's 13F filing for Q1 2017, filed 15 May 2017.